Loading page
Retatrutide + Cagrilintide Blend
Retatrutide + Cagrilintide
Retatrutide and cagrilintide blend, 45mg combined content
£199.99
1
Retatrutide + Cagrilintide£199.99
- Check the batch. Match the batch on your product label to the available laboratory report.
- Read the original report. View test certificates and availability for your selected strength.
- Buyer guarantee. Arrives damaged or not matching its certificate? We’ll replace it or refund you.
Specification
- Form
- Prefilled research pen
- Storage
- Follow the storage conditions on the supplied product label.
- Purity
- Specification pending verification
Specification for this lot is undergoing independent verification. Figures shown are provisional pending certificate of analysis.
For research and laboratory use only. Not for human consumption, diagnostic, or therapeutic use.
Test certificates
Retatrutide + Cagrilintide · 45mg · Certificate pending
A test certificate for Retatrutide + Cagrilintide 45mg has not been published yet. We will add it here when it is available.
The full picture
A single prefilled pen labelled with retatrutide 40mg and cagrilintide 5mg, giving 45mg combined content. Retatrutide acts on the GIP, GLP-1 and glucagon receptors; cagrilintide is an amylin analogue.
This listing is one blended pen. The separate-pen bundle contains retatrutide 40mg and cagrilintide 10mg. Studies of the individual compounds do not establish the effects of this blend.
Compound research references
- Retatrutide receptor structure and activity (2024) (opens in a new tab)
- Development of the amylin analogue cagrilintide (2021) (opens in a new tab)
These references describe the compounds. They do not certify the supplied product or batch.
What customers say
—0 reviews
No reviews yet — be the first to review Retatrutide + Cagrilintide.
